As I understand it the administration doesn't want to wait until the FDA conducts its usual lengthy and comprehensive double blind trials on the efficacy of boosters. It seems to be relying in part on data from Israel and saying that waiting in the midst of a public health emergency might not be such a good idea. Funny that I seem to recall you making a similar argument with respect to full regulatory approval. In effect not waiting to dot all the i's and cross all the t's in a public health emergency when a good bit of evidence exists on the need for a booster. Dr. Gounder is advocating for sticking to the slow regulatory approach you have elsewhere deplored.
Btw I've seen a better more sophisticated argument against boosters, which is that you get a better bang for the buck by disseminating vaccines to poor countries and helping to hold down infectious spread on a global basis. While I appreciate the logic behind it, that argument is a very tough sell politically. Grandma and grandpa dying so we can protect some farmer in Kenya. The headline writes itself.
